Jodie Morrison, Chief Executive Officer and a member of the Board of Directors of Q32 Bio, Inc., brings biopharmaceutical leadership experience from private start up through commercial public biotechnology and pharmaceutical companies. Jodie was previously Chief Executive Officer of Cadent Therapeutics until its sale to Novartis in 2020. Jodie also served as Venture Partner of Atlas Venture, interim Chief Executive Officer of Keryx Biopharmaceuticals, Inc. (executed the merger of equals with Akebia Therapeutics, Inc. in 2018), acting Chief Operating Officer of Syntimmune, Inc. (acquired by Alexion Pharmaceuticals, Inc.), and President and Chief Executive Officer of Tokai Pharmaceuticals, Inc., where she oversaw the company’s successful initial public offering (IPO) in 2014. Prior, Jodie held other senior positions with the company, including Chief Operating Officer and Head of Clinical Affairs and Program Operations. Earlier in her career, Jodie held roles in clinical operations and medical affairs at Dyax Corporation, Curis, Inc. and Diacrin, Inc.
Jodie founded and currently runs The CEO Forum, which has supported CEOs through challenges including the COVID-19 pandemic, the SVB banking crisis, the Inflation Reduction Act and the recent evolution of the BIOSECURE Act. Jodie currently serves as a member of the Board of Directors of Rectify Pharmaceuticals, Inc. and was previously a board member of Akebia Therapeutics, Inc., Aileron Therapeutics, Inc., Keryx Biopharmaceutics, Inc., Eledon Pharmaceuticals, Inc. (formerly Novus Therapeutics) and Ribon Therapeutics, Inc (chair). Jodie also serves on the Board of Managers of Life Science Cares (LSC). Jodie holds a B.A. in Neuroscience from Mount Holyoke College, completed her business training in the Greater Boston Executive Program at the MIT Sloan School of Management and her clinical research certification from Boston University School of Medicine.
What is Jodie Pope Morrison's net worth?
The estimated net worth of Jodie Pope Morrison is at least $1.80 million as of February 25th, 2026. Ms. Morrison owns 89,104 shares of Q32 Bio stock worth more than $1,797,851 as of July 14th. This net worth evaluation does not reflect any other investments that Ms. Morrison may own. Learn More about Jodie Pope Morrison's net worth.
How do I contact Jodie Pope Morrison?
Has Jodie Pope Morrison been buying or selling shares of Q32 Bio?
Jodie Pope Morrison has not been actively trading shares of Q32 Bio over the course of the past ninety days. Most recently, Jodie Pope Morrison sold 9,896 shares of the business's stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $4.51, for a transaction totalling $44,630.96. Following the completion of the sale, the chief executive officer now directly owns 89,104 shares of the company's stock, valued at $401,859.04. Learn More on Jodie Pope Morrison's trading history.
Are insiders buying or selling shares of Q32 Bio?
In the last year, Q32 Bio insiders bought shares 2 times. They purchased a total of 3,750,000 shares worth more than $30,000,000.00. In the last year, insiders at the sold shares 8 times. They sold a total of 66,008 shares worth more than $216,507.14. The most recent insider tranaction occured on May, 28th when Director Diyong Xu bought 1,875,000 shares worth more than $15,000,000.00. Insiders at Q32 Bio own 34.5% of the company.
Learn More about insider trades at Q32 Bio. Information on this page was last updated on 5/28/2026.
